RENAZORB Trademark

Trademark Overview

On Monday, July 25, 2011, a trademark application was filed for RENAZORB with the United States Patent and Trademark Office. The USPTO has given the RENAZORB trademark a serial number of 85380174. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, April 30, 2023. This trademark is owned by Spectrum Pharmaceuticals, Inc.. The RENAZORB trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL COMPOSITIONS CONTAINING LANTHANUM USED TO DECREASE THE SERUM PHOSPHATE LEVELS IN HUMANS AND OTHER MAMMALS WITH HYPERPHOSPHATEMIA
renazorb

General Information

Serial Number85380174
Word MarkRENAZORB
Filing DateMonday, July 25, 2011
Status800 - REGISTERED AND RENEWED
Status DateSunday, April 30, 2023
Registration Number4234946
Registration DateTuesday, October 30, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2011

Trademark Statements

Amendment to a Registration/Renewal CertificateIssue New Certificate to: UNICYCIVE THERAPEUTICS, INC. (CORPORATION DELAWARE) 5150 EL CAMINO REAL, SUITE #A-32, LOS ALTOS CA, 94022.
Goods and ServicesPHARMACEUTICAL COMPOSITIONS CONTAINING LANTHANUM USED TO DECREASE THE SERUM PHOSPHATE LEVELS IN HUMANS AND OTHER MAMMALS WITH HYPERPHOSPHATEMIA

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 28, 2011
Primary Code005
First Use Anywhere DateFriday, April 13, 2012
First Use In Commerce DateFriday, April 13, 2012

Trademark Owner History

Party NameUNICYCIVE THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLos Altos, CA 94022
Party NameSpectrum Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Altos, CA 94022
Party NameSpectrum Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSpectrum Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Sunday, April 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, April 30, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, April 30, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 27, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 13, 2022TEAS SECTION 8 & 9 RECEIVED
Thursday, August 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 30, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 25, 2019NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Thursday, July 25, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 16, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 10, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 9, 2019TEAS SECTION 7 REQUEST RECEIVED
Saturday, June 8, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 8, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, June 8, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 29, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, October 30, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 30, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, October 3, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, September 27, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 26, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, September 26, 2012ASSIGNED TO LIE
Monday, September 17, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 23, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 22, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, August 13, 2012USE AMENDMENT FILED
Wednesday, August 22, 2012SOU EXTENSION 1 GRANTED
Monday, August 13, 2012SOU EXTENSION 1 FILED
Wednesday, August 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 13, 2012SOU TEAS EXTENSION RECEIVED
Monday, August 13, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, February 14, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 15, 2011ASSIGNED TO EXAMINER
Thursday, July 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2011NEW APPLICATION ENTERED

Related Keywords

renazorb humans levels other mammals hyperphosphatemia phosphate serum containing compositions lanthanum